MeritValue

ENDONOVO THERAPEUTICS, INC.

ENDVdata completeness 75%13 fiscal years on file
i. The business — what you’d actually own
FigureFY 2018FY 2019FY 2020FY 2021FY 2022
Revenue$83,2631$310,1642$165,7963$73,1054$135,3554
Net income−$6.44M5−$17.3M6−$395,5847−$3.1M8−$18.5M8
Operating cash flow−$2.88M9−$2.54M10−$741,59011−$986,58412−$678,83812
Capital expenditure$8,96913$2,59414———
Free cash flow (derived)−$2.89M9−$2.54M10———
Total debt$8.16M15$6.87M16$6.84M17$7.26M18$7.15M19
Cash & equivalents$379,15120$18,89321$13,42022$85,93622—
Diluted shares431,0631.2M24.5M59.8M139.2M

Superscripts are receipts. Each links to the SEC filing the number came from (full list at the bottom).

ii. Your slice — ownership made literal
If you owned
shares
Net assets behind them
−$2.31
your share of equity
Profit it earned you last year
−$1.33
Free cash flow it threw off
—
Debt you’d be carrying
$0.51

10 shares is a claim on −$2.31 of net worth that earned you −$1.33 last year, against $0.51 of debt.

iii. Is this a good business?
Moat signal · return on equity
— avg · 5y

Not enough data in the filings for a return-on-capital reading.

seeing a moat in the numbers →
Management signal · capital allocation
+32194% shares · 5y

Share count is up 32194% over 5 years — owners have been diluted. Worth asking what they got for it. Total debt has fallen 12% — deleveraging.

reading capital allocation →

Signals, not verdicts — read from the filings above. Numbers don’t prove a moat; they show its footprint. You decide.

iv. What it’s worth — engine v0.1.0
DCF · Growth Exit 10Y
not applicable
only 2 years of FCF (need ≥3) — model not applicable
DCF · Growth Exit 5Y
not applicable
only 2 years of FCF (need ≥3) — model not applicable
Earnings Power Value
not applicable
normalized (5y-median) earnings non-positive — EPV undefined
Graham Number
not applicable
diluted EPS missing or non-positive — Graham Number undefined

Different models answer different questions — which to trust when →

Sources — the receipts
  1. 10-K · period ending 2018-12-31 · accession 0001493152-20-007577 (RevenueFromContractWithCustomerExcludingAssessedTax)
  2. 10-K · period ending 2019-12-31 · accession 0001493152-21-008661 (RevenueFromContractWithCustomerExcludingAssessedTax)
  3. 10-K · period ending 2020-12-31 · accession 0001493152-22-009861 (RevenueFromContractWithCustomerExcludingAssessedTax)
  4. 10-K · period ending 2021-12-31 · accession 0001493152-23-012553 (RevenueFromContractWithCustomerExcludingAssessedTax)
  5. 10-K · period ending 2018-12-31 · accession 0001493152-20-007577 (NetIncomeLoss)
  6. 10-K · period ending 2019-12-31 · accession 0001493152-21-008661 (NetIncomeLoss)
  7. 10-K · period ending 2020-12-31 · accession 0001493152-22-009861 (NetIncomeLoss)
  8. 10-K · period ending 2021-12-31 · accession 0001493152-23-012553 (NetIncomeLoss)
  9. 10-K · period ending 2018-12-31 · accession 0001493152-20-007577 (NetCashProvidedByUsedInOperatingActivities)
  10. 10-K · period ending 2019-12-31 · accession 0001493152-21-008661 (NetCashProvidedByUsedInOperatingActivities)
  11. 10-K · period ending 2020-12-31 · accession 0001493152-22-009861 (NetCashProvidedByUsedInOperatingActivities)
  12. 10-K · period ending 2021-12-31 · accession 0001493152-23-012553 (NetCashProvidedByUsedInOperatingActivities)
  13. 10-K · period ending 2018-12-31 · accession 0001493152-20-007577 (PaymentsToAcquirePropertyPlantAndEquipment)
  14. 10-K · period ending 2019-12-31 · accession 0001493152-21-008661 (PaymentsToAcquirePropertyPlantAndEquipment)
  15. 10-K · period ending 2018-12-31 · accession 0001493152-19-005267 (LongTermDebt)
  16. 10-K · period ending 2019-12-31 · accession 0001493152-20-007577 (LongTermDebt)
  17. 10-K · period ending 2020-12-31 · accession 0001493152-21-008661 (LongTermDebt)
  18. 10-K · period ending 2021-12-31 · accession 0001493152-22-009861 (LongTermDebt)
  19. 10-K · period ending 2022-12-31 · accession 0001493152-23-012553 (LongTermDebt)
  20. 10-K · period ending 2018-12-31 · accession 0001493152-20-007577 (CashAndCashEquivalentsAtCarryingValue)
  21. 10-K · period ending 2019-12-31 · accession 0001493152-21-008661 (CashAndCashEquivalentsAtCarryingValue)
  22. 10-K · period ending 2020-12-31 · accession 0001493152-22-009861 (CashAndCashEquivalentsAtCarryingValue)